BioTech 365

NOVEMBER 12, 2021

Biotechnology, Pharma and Biopharma News – Research – Science – Lifescience ://Biotech-Biopharma-Pharma: SITC: Cellectis’ off-the-shelf CAR-T for pancreatic cancer and mesothelioma shows activity in mice.SITC: Cellectis’ off-the-shelf CAR-T for pancreatic cancer and mesothelioma shows activity in mice arlene.weintraub (..)

Research 40

Research 40

BioTech 365

FEBRUARY 8, 2021

Biotechnology, Pharma and Biopharma News – Research – Science – Lifescience ://Biotech-Biopharma-Pharma: Boosting the response to immuno-oncology in pancreatic cancer by targeting inflammation.Boosting the response to immuno-oncology in pancreatic cancer by targeting inflammation arlene.weintraub Mon, 02/08/2021 – 09:45 from (..)

Research 40

Research 40

BioTech 365

MAY 6, 2021

Biotechnology, Pharma and Biopharma News – Research – Science – Lifescience ://Biotech-Biopharma-Pharma: A cancer vaccine built from stem cells? Stanford candidate shows promise in pancreatic tumors.A cancer vaccine built from stem cells?

Vaccination 40

Vaccination Vaccine Research 40

Pharma Times

AUGUST 3, 2023

The candidate is a stroma-degrading oncolytic adenovirus for the treatment of pancreatic cancer - News - PharmaTimes

97

97

Drug Discovery World

JANUARY 24, 2024

The Phase IIa ACCENT trial has launched to explore the activity of focal adhesion kinase (FAK) inhibitor narmafotinib in combination with standard-of-care chemotherapy in advanced pancreatic cancer patients. FOLFIRINOX is a four drug chemotherapy regimen that is widely employed in the US for the treatment of pancreatic cancer.

Trials 52

Trials Clinical Trials Clinical Trials Drugs 52

Drug Discovery World

JANUARY 26, 2024

News round-up for 22-26 January by DDW Digital Content Editor Diana Spencer. In the same week that it was revealed that breast cancer was the most studied disease area in 2023 for the third year running, there were a number of promising developments in the treatment of colorectal, pancreatic and lung cancer and leukaemia.

Drugs 52

Drugs Trials Research Development 52

Medical Xpress

MARCH 1, 2023

A large team of cancer researchers affiliated with multiple institutions in Germany, working with a colleague from the U.S., has discovered some of the ways gut bacteria can positively impact treatments for cancer.

Bacteria 97

Bacteria Research 97

Drug Discovery World

APRIL 12, 2024

News round-up for 8-12 April by DDW Digital Content Editor Diana Spencer. The cancer research news has been coming thick and fast from the American Association of Cancer Research (AACR) Annual Meeting in San Diego this week, so our Friday round-up focuses on drug discovery in oncology.

Drugs 52

Drugs Genetic Engineering Immune Response Engineer 52

STAT News

APRIL 10, 2023

When Jeannette Cleland learned earlier this year that she could get chemotherapy at home, after dropping a particularly toxic medication, it seemed like good news. But then Cleland, a 44-year-old Minneapolis event planner who has stage 4 pancreatic cancer, did the math.

Nurses 98

Nurses Drugs Clinical Trials Clinical Trials 98

Drug Discovery World

JANUARY 6, 2023

News round-up for 2-6 January by DDW Digital Content Editor Diana Spencer. The drug discovery industry has hit the ground running in 2023 with some big announcements in the first week, particularly in cancer research, where there has been good news in pancreatic, urothelial and uveal cancers. . The top stories:

Drugs 52

Drugs Antibody Clinical Trials Clinical Trials 52

Drug Discovery World

MARCH 31, 2023

News round-up for 27-31 March by DDW Digital Content Editor Diana Spencer. As March draws to a close, this week’s key announcements have demonstrated the breadth of international approaches to tackling cancer, with vaccines, proenzymes, immunotherapies and antibody-based treatments all currently under investigation around the world.

Drugs 52

Drugs Antibody Vaccination Vaccine 52

Drug Discovery World

MARCH 24, 2023

News round-up for 20-24 March by DDW Digital Content Editor Diana Spencer. Pennsylvania researchers may have found a way to boost CAR-T therapy in these tumours, previously only successful in blood cancers, which could have huge implications for cancer treatment.

Drugs 52

Drugs Hormones Trials Research 52

BioTech 365

NOVEMBER 3, 2021

NOXXON Provides Update on Timing for Upcoming Trials of NOX-A12 in Pancreatic and Brain Cancer NOXXON Provides Update on Timing for Upcoming Trials of NOX-A12 in Pancreatic and Brain Cancer BERLIN–(BUSINESS WIRE)–Regulatory News: NOXXON Pharma N.V.

Trials 40

Trials 40

Drug Discovery World

JANUARY 9, 2023

The drug discovery industry has hit the ground running in 2023 with some big announcements in the first week, particularly in cancer research, where there has been good news in pancreatic, urothelial and uveal cancers. The post DDW Highlights: 9 January 2023 appeared first on Drug Discovery World (DDW).

Drugs 52

Drugs Research 52

Drug Discovery World

JANUARY 9, 2023

The drug discovery industry has hit the ground running in 2023 with some big announcements in the first week, particularly in cancer research, where there has been good news in pancreatic, urothelial and uveal cancers.

Drugs 52

Drugs Research Antibody Vaccination 52

The Pharma Data

OCTOBER 16, 2020

UEG: Pancreatic CA Down With Bariatric Sx for Obese With DM. 16, 2020 — For patients with diabetes mellitus and obesity, bariatric surgery (BS) is associated with a reduced prevalence of pancreatic cancer compared with no BS, according to a study presented at UEG Week Virtual 2020, held Oct. More News Resources.

Research 52

Research 52

Drug Discovery World

MARCH 3, 2023

News round-up for 27 February – 3 March by DDW Digital Content Editor Diana Spencer. As well as providing extensive coverage of the SLAS2023 meeting in San Diego and Rare Disease Day , DDW has also reported on a number of developments in cancer drug discovery this week.

Drugs 52

Drugs Gene Expression Genome Genomics 52

BioTech 365

FEBRUARY 8, 2021

NOXXON Appoints Leading Pancreatic Cancer Experts to Scientific Advisory Board NOXXON Appoints Leading Pancreatic Cancer Experts to Scientific Advisory Board BERLIN–(BUSINESS WIRE)–Regulatory News: NOXXON Pharma N.V.

40

40

The Pharma Data

NOVEMBER 18, 2020

18, 2020 — When actor, writer and producer Mindy Kaling’s mom was fighting pancreatic cancer , it was the biggest struggle the family had ever experienced. Pancreatic cancer is the third-leading cause of cancer-related deaths in the United States, PanCAN said in a news release. WEDNESDAY, Nov.

Research 52

Research Branding Trials 52

Drug Discovery World

JUNE 2, 2023

News round-up for 29 May – 2 June by DDW Digital Content Editor Diana Spencer. With National Cancer Research Month coming to an end and the American Society of Clinical Oncology Annual Meeting currently taking place in Chicago (2-6 June), it’s been another busy week for cancer drug development news.

Drugs 52

Drugs HR Antibody Clinical Trials 52

Pharmaceutical Technology

MAY 12, 2023

Matinas announced the news in a May 10 statement. The news means the collaboration between the two companies lasted just over a year. Whilst BioNTech has shelved its oral mRNA vaccine project, shares were up this week following promising early results of a personalised mRNA vaccine for pancreatic cancer.

Vaccination 130

Vaccination Vaccine In-Vivo In-Vitro 130

pharmaphorum

JANUARY 23, 2023

Ipsen and partner Servier hope to extend the uses of their pancreatic cancer therapy Onivyde into the first-line treatment setting, assisted by new phase 3 data reported at the ASCO-GI 2023 congress. Abraxane/gemcitabine was associated with higher rates of anaemia and neutropenia.

Sales 52

Sales Drugs 52

The Pharma Data

JANUARY 27, 2021

27, 2021 — Aspirin use may improve survival for bladder and breast cancer , according to a study published online Jan. years) participating in the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial (1993 to 2001). The researchers found that aspirin use was not associated with the incidence of any studied cancer type.

Trials 52

Trials Development Research 52

Drug Discovery World

APRIL 8, 2024

The American Association of Cancer Research (AACR) Annual Meeting launched on Sunday 7 April in San Diego with an Opening Plenary Session showcasing cutting-edge technological advances opening new frontiers in cancer science.

In-Vivo 52

In-Vivo In-Vitro Antibody Protein 52

The Pharma Data

DECEMBER 29, 2020

Food and Drug Administration granted marketing authorization to the EndoRotor System, which provides a minimally invasive way to resect and remove necrotic tissue for patients with walled-off pancreatic necrosis (WOPN), the agency announced last week. More News Resources. Professional. FDA Authorizes Marketing of EndoRotor System.

Marketing 52

Marketing Trials Development Drugs 52

pharmaphorum

JANUARY 23, 2023

Takeda has taken rights outside China, Hong Kong and Macau to Hutchmed’s colorectal cancer therapy fruquintinib , a small molecule vascular endothelial growth factor receptors (VEGFR) 1, 2 and 3 taken as a once daily pill that is in late-stage development in the US, Europe and Japan with filings due later this year.

Licensing 52

Licensing Licensing Sales Marketing 52

XTalks

JANUARY 7, 2022

Researchers at the University of Oxford have developed a blood test for the detection of different cancers, and the test can also determine whether a cancer has metastasized. Additionally, the cancer blood test can spot disease in patients that have non-specific symptoms and can help clinicians determine the stage of a cancer.

Research 98

Research Development 98

World of DTC Marketing

MAY 16, 2022

Mounjaro, Lilly’s new diabetes drug, is sure to be in high demand initially after launch, but patients should be aware of its side effects. According to Lilly side, the effects include “Mounjaro may cause tumors in the thyroid, including thyroid cancer and Inflammation of the pancreas (pancreatitis).”

Drugs 218

Drugs Pharma Companies Clinical Trials Clinical Trials 218

Drug Discovery World

JULY 25, 2023

These include two antibodies for modulating immune responses in cancer and autoimmunity, which are being advanced through pharmaceutical partnerships with Novartis and GlaxoSmithKline. The breakthrough So what was the point at which the cancer immunotherapy breakthrough started to feel real?

Immune Response 98

Immune Response Gene Protein Antibody 98

Drug Discovery World

APRIL 14, 2023

The American Association for Cancer Research (AACR) will honour the following cancer researchers, physician-scientists, advocates, and journalists during its annual meeting to be held April 14-19 at the Orange County Convention Center in Orlando, Florida. June’s award lecture will be held on Sunday April 16 at 4:30pm ET.

Genetics 52

Genetics Research Medicine Clinical Research 52

The Pharma Data

NOVEMBER 24, 2020

25, 2020 /CNW/ – On August 21, 2020 , Health Canada approved Lynparza® (olaparib), for the treatment of adult patients with deleterious or suspected deleterious germline and/or somatic BRCA or ATM- mutated metastatic castration-resistant prostate cancer (mCRPC) who have progressed following prior treatment with a new hormonal agent (NHA).

Gene 52

Gene Hormones DNA Medicine 52

The Pharma Data

JANUARY 7, 2021

RMI), a global biotechnology company developing precision-targeted cancer therapies based on its proprietary, anti-cancer treatment platform, Illuminox , will present at the 39th Annual J.P. Rakuten Medical is committed to its mission to conquer cancer and aims to realize a society where cancer patients can lead fulfilling lives.

Clinical Trials 52

Clinical Trials Clinical Trials Antibody Development 52

The Pharma Data

OCTOBER 19, 2020

Two presentations will be delivered by Nanobiotix and two will be delivered by the University of Texas MD Anderson Cancer Center. 11 from 12:15 pm – 12:25 pm EST. In the United States, the Company has started the regulatory process to commence a phase III clinical trial in locally advanced head and neck cancers.

Containment 52

Containment Clinical Trials Clinical Trials Immune Response 52

The Pharma Data

MAY 19, 2023

“Congratulations to the Regeneron International Science and Engineering Fair 2023 winners,” said Maya Ajmera, President and CEO, Society for Science and Executive Publisher, Science News. “I Detecting these cancers before they metastasize could make treatment much simpler and more effective.

Engineer 52

Engineer Scientist Protein Research 52

The Pharma Data

NOVEMBER 9, 2020

The results were presented at The Society for the Immunotherapy of Cancer 35 th Anniversary Annual Meeting. Addressing Unmet Needs in Cancer Immunotherapy. Taken together, these barriers present a significant unmet need to improve the efficacy ICIs and expand their potentially curative benefits to more patients with advanced cancers.

Immune Response 40

Immune Response Containment Trials Clinical Trials 40

The Pharma Data

DECEMBER 9, 2020

Below is a roundup of some of this week’s interesting news. The company also announced the successful in vivo validation of the platform in proof-of-concept studies using a cancer xenograft model. The creation of Overland isn’t the only exciting thing happening for international life sciences companies and organizations.

In-Vivo 52

In-Vivo In-Vitro Antibody Development 52

Pharma Times

FEBRUARY 21, 2024

Results showed robust responses in patients with pancreatic and colorectal cancer

Vaccination 111

Vaccination Vaccine Trials 111